Literature DB >> 29652079

Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival.

N Ironside1, S G Barreto2,3, B Loveday1,4, S V Shrikhande5, J A Windsor1,4, S Pandanaboyana1,4.   

Abstract

BACKGROUND: The aim of this systematic review and meta-analysis was to evaluate perioperative outcomes and survival in patients undergoing an artery-first approach to pancreatoduodenectomy in comparison with those having standard pancreatoduodenectomy.
METHODS: A systematic search of PubMed, MEDLINE, Embase and the Cochrane Database of Systematic Reviews was performed in accordance with PRISMA guidelines. Comparative studies including patients who underwent artery-first pancreatoduodenectomy and standard pancreatoduodenectomy were analysed.
RESULTS: Seventeen studies were included in the final analysis. There were 16 retrospective cohort or case-control studies and one RCT. A total of 1472 patients were included in the meta-analysis, of whom 771 underwent artery-first pancreatoduodenectomy and 701 had standard pancreatoduodenectomy. Intraoperative blood loss (mean difference -389 ml; P < 0·001) and the proportion of patients requiring intraoperative transfusion (10·6 per cent (54 of 508) versus 40·1 per cent (186 of 464); P < 0·001) were significantly lower in the artery-first group. Although rates of perioperative mortality were comparable between the two groups, perioperative morbidity (35·5 per cent (263 of 741) versus 44·3 per cent (277 of 625); P = 0·002), and the incidence of grade B/C pancreatic fistula (7·4 per cent (26 of 353) versus 12·8 per cent (42 of 327); P = 0·031) were significantly lower in the artery-first group. The R0 resection rate (75·8 per cent (269 of 355) versus 67·0 per cent (280 of 418); P < 0·001) and overall survival (hazard ratio 0·72, 95 per cent c.i. 0·60 to 0·87; P < 0·001) were significantly higher in the artery-first group.
CONCLUSION: The artery-first approach to pancreatoduodenectomy may be associated with improved perioperative outcomes and survival.
© 2018 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29652079     DOI: 10.1002/bjs.10832

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Morphological speculation of the MHPD and related clinical projections.

Authors:  Yue Gao; Runjing Wang; Yungang Lai; Yue Xu; Wei Lv; Jungui Liu; Yuanshan Fu; Weihong Duan
Journal:  Surg Radiol Anat       Date:  2021-03-04       Impact factor: 1.246

Review 2.  Resection of Recurrent Pancreatic Cancer: Who Can Benefit?

Authors:  Henrik Nienhüser; Markus W Büchler; Martin Schneider
Journal:  Visc Med       Date:  2021-11-11

3.  Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.

Authors:  Georgios Gemenetzis; Alex B Blair; Minako Nagai; William R Burns; Christopher L Wolfgang; Jin He; Vincent P Groot; Ding Ding; Ammar A Javed; Richard A Burkhart; Elliot K Fishman; Ralph H Hruban; Matthew J Weiss; John L Cameron; Amol Narang; Daniel Laheru; Kelly Lafaro; Joseph M Herman; Lei Zheng
Journal:  Ann Surg Oncol       Date:  2021-08-27       Impact factor: 5.344

Review 4.  [Surgical treatment of pancreatic cancer-What is new?]

Authors:  Thomas Schmidt; Orlin Belyaev; Waldemar Uhl; Christiane J Bruns
Journal:  Chirurg       Date:  2022-03-31       Impact factor: 0.955

5.  Comparison of perioperative outcomes in pancreatic head cancer patients following either a laparoscopic or open pancreaticoduodenectomy with a superior mesenteric artery first approach.

Authors:  Min Young Park; Woohyung Lee; Jaewoo Kwon; Ki Byung Song; Dae Wook Hwang; Jae Hoon Lee; Song Cheol Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-08-31

Review 6.  What do surgeons need to know about the mesopancreas.

Authors:  Eduardo de Souza M Fernandes; Oliver Strobel; Camila Girão; Jose Maria A Moraes-Junior; Orlando Jorge M Torres
Journal:  Langenbecks Arch Surg       Date:  2021-06-12       Impact factor: 3.445

7.  Robotic-assisted versus open total pancreatectomy: a propensity score-matched study.

Authors:  Yuanchi Weng; Mengmin Chen; Georgios Gemenetzis; Yusheng Shi; Xiayang Ying; Xiaxing Deng; Chenghong Peng; Jiabin Jin; Baiyong Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2020-12       Impact factor: 7.293

Review 8.  Optimizing the outcomes of pancreatic cancer surgery.

Authors:  Oliver Strobel; John Neoptolemos; Dirk Jäger; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2019-01       Impact factor: 66.675

Review 9.  Conversion Surgery for Advanced Pancreatic Cancer.

Authors:  Thomas Hank; Oliver Strobel
Journal:  J Clin Med       Date:  2019-11-12       Impact factor: 4.241

10.  Postoperative complications and mobilisation following major abdominal surgery with vs. without fitness tracker-based feedback (EXPELLIARMUS): study protocol for a student-led multicentre randomised controlled trial (CHIR-Net SIGMA study group).

Authors:  Marius Schwab; Niall Brindl; Alexander Studier-Fischer; Thomas Tu; Julia Gsenger; Max Pilgrim; Mirco Friedrich; Pia-Elena Frey; Christina Achilles; Alexander Leuck; Thore Bürgel; Manuel Feisst; Christina Klose; Solveig Tenckhoff; Colette Dörr-Harim; André L Mihaljevic
Journal:  Trials       Date:  2020-03-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.